
| PROFIT CONSOLIDATED ENTITIES | ||
| SG$ | 2009 | 2008 |
| Net sales ($ million) | 137 | 152 |
| Change (%) | (9.9) | |
| PBIT ($ million) | 15.5 | 11.3 |
| Change (%) | 37.2 | |
| Operating margin (%) | 11.3 | 7.5 |
| Average funds employed ($ million) | 55 | 73 |
| PBIT/AFE(%) | 28.2 | 15.5 |
| Average exchange rate A$/SG$ | 1.11 | 1.29 |
| EQUITY ACCOUNTED PROFIT | ||
| SG$ | 2009 | 2008 |
| PAT ($ million) | 37.7 | 35.9 |
| Change (%) | 5.0 | |
| Average funds employed |
389 | 192 |
| Average funds employed |
581 | 382 |
| PAT/AFE |
9.7 | 18.7 |
| PBIT/AFE |
6.5 | 9.4 |
| (1) Including AMVIG fair value adjustment (2) Excluding AMVIG fair value adjustment |
||
Amcor Asia consists of:
As AMVIG has not yet reported its half year earnings to 30 June 2009, the profit taken up in Amcor Asia’s full year earnings is the actual result for the six months to 31 December 2008, plus management’s estimate of earnings for the period January to June 2009, based on publicly available information. Any adjustment required following the announcement of AMVIG’s profit will be taken up in Amcor Asia’s 2009/10 first half results.
During the year, Amcor’s ownership in AMVIG increased from 35.4% to 38.9%. This increase was primarily due to Amcor investing HK$700 million to acquire 78.3 million shares in AMVIG at a price of HK$8.94 per share.
CONSOLIDATED ENTITIES
For the controlled entities, PBIT for the year was 37.2% higher at SG$15.5 million. Returns, measured as PBIT over average funds employed, increased from 15.5% to 28.2%.
The wholly-owned tobacco packaging operations continued to deliver sound operating performance and benefited from the upgrading of the printing capabilities at the plant in Malaysia. The business experienced strong volumes in the first half of the year, however volumes were weaker in the second half due to the loss of some important contract volumes. Although these volumes are being replaced, it is likely that volumes in 2009/10 will be lower.
The flexibles operations continued to deliver solid earnings with the new plant in Southern China creating the opportunity for more accelerated growth in the region.
FOOTNOTE
The funds invested in AMVIG, as reported in Amcor’s accounts at 30 June 2009, consist of cash payments of SG$281 million to purchase 424.5 million shares in the publicly-listed company at an average price of HK$5.01 per share, together with the injection of the two tobacco packaging operations in China (Beijing and Qingdao), which had a carrying value of SG$69 million.
The carrying value of AMVIG at 30 June 2009 in Amcor’s accounts is SG$589.9 million, with the difference between this amount and the invested funds being predominantly accounting adjustments for ‘fair value market up-lift’ at the time of exercising options to acquire additional shares.
| CASH FLOW ALL OPERATIONS | |
| SG$ million | 2009 |
| PBITDA (consolidated entities) | 22.2 |
| Change (%) | 32.1 |
| Dividends received | 7.3 |
| Base capital expenditure | (5.1) |
| Movement in working capital | 13.9 |
| Significant items | – |
| Operating cash flow | 38.3 |
| Growth capital expenditure | – |
| Acquistions | (122.7) |